Pierre Hirsch
- Hematology top 5%
- Acute Myeloid Leukemia Research 22
- Chronic Myeloid Leukemia Treatments 9
- Multiple Myeloma Research and Treatments 4
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 13
- Rheumatology top 10%
- Otitis Media and Relapsing Polychondritis 4
-
- Drug Transport and Resistance Mechanisms 4
-
- Acute Lymphoblastic Leukemia research 5
-
- Childhood Cancer Survivors' Quality of Life 3
- Co-authors
- François DelhommeauOllivier LegrandChristophe MarzacSimona LapusanRuoping TangJean‐Pierre MarieFrancesca FavaFanny Fava
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- FranceUnited StatesTürkiye
In The Last Decade
Pierre Hirsch
36 papers receiving 559 citations
Peers
Comparison fields: 5 of 57
- Hematology 294
- Genetics 158
- Rheumatology 100
- Oncology 143
- Cancer Research 63
Countries citing papers authored by Pierre Hirsch
This map shows the geographic impact of Pierre Hirsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Hirsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Hirsch more than expected).
Fields of papers citing papers by Pierre Hirsch
This network shows the impact of papers produced by Pierre Hirsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Hirsch. The network helps show where Pierre Hirsch may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pierre Hirsch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 6 | |
| 3 | 2021 | 20 | |
| 4 | 2020 | 24 | |
| 5 | 2020 | 33 | |
| 6 | 2019 | 9 | |
| 7 | 2019 | 15 | |
| 8 | 2019 | 11 | |
| 9 | 2018 | 8 | |
| 10 | 2018 | 33 | |
| 11 | 2017 | 1 | |
| 12 | 2017 | 38 | |
| 13 | 2016 | 33 | |
| 14 | 2016 | 1 | |
| 15 | 2014 | 11 | |
| 16 | 2014 | 7 | |
| 17 | 2012 | 39 | |
| 18 | 2011 | 20 | |
| 19 | 2010 | 22 | |
| 20 | 2009 | 43 |
About Pierre Hirsch
Pierre Hirsch is a scholar working on Hematology, Genetics, Rheumatology, Pathology and Forensic Medicine and Oncology, having authored 39 papers that have together received 568 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Chronic Myeloid Leukemia Treatments (9 papers), Acute Lymphoblastic Leukemia research (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Multiple Myeloma Research and Treatments (4 papers), Otitis Media and Relapsing Polychondritis (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). The work is most often cited by research in Hematology (294 citations), Genetics (158 citations), Rheumatology (100 citations), Oncology (143 citations) and Cancer Research (63 citations). Pierre Hirsch has collaborated with scholars based in France, United States and Türkiye. Frequent co-authors include François Delhommeau, Ollivier Legrand, Christophe Marzac, Simona Lapusan, Ruoping Tang, Jean‐Pierre Marie, Francesca Fava, Fanny Fava, Mohamad Mohty and A. Mékinian. Their work appears in journals such as Haematologica, Blood, Leukemia Research, Lara D. Veeken and Genes Chromosomes and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.